Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine

NCT05285384 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant

Sponsor

Cinnagen

Collaborators

[object Object]
[object Object]